Announcements Trials

Browse Landscape

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Observational 1

Sponsor

Cancer Type

Other hematologic neoplasm 2 Thoracic 1 Head & Neck 1 Breast 1

Conditions

Lung Neoplasms 1

Interventions

Carboplatin 463 Cisplatin 379 Paclitaxel 313 Pemetrexed 300 Docetaxel 242 Erlotinib Hydrochloride 240 Gemcitabine 232 pembrolizumab 173 Radiotherapy 172 Bevacizumab 169 Nivolumab 130 Etoposide 106 Gefitinib 95 Vinorelbine 84 durvalumab 71 atezolizumab 68 Cetuximab 65 Topotecan 61 Drug Therapy 57 Ipilimumab 55 Irinotecan 54 osimertinib 53 Radiosurgery 52 Afatinib 51 Surveys and Questionnaires 38 130-nm albumin-bound paclitaxel 38 Albumin-Bound Paclitaxel 37 Taxes 35 Cyclophosphamide 35 Surgical Procedures, Operative 34

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Blood Cell Count × Thoracic × Clear all

NCT03749512 2018-11-21

NLCR in Prediction of the Grade of Lung Tumor.

Medical University of Silesia

Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡